ARTICLE | Clinical News
ThPTH: Phase I
December 22, 2003 8:00 AM UTC
TH started a controlled, U.K. Phase I trial in 10-30 healthy volunteers comparing ThPTH to Forteo teriparatide, a recombinant form of PTH 1-34 marketed by Eli Lilly and Co. (LLY, Indianapolis, Ind....